Abstract
Parkinson’s disease (PD) is a prevalent age-related neurodegenerative disease which is modulated by various molecules, including long non-coding RNAs (lncRNAs). LncRNA H19 has been shown to be associated with PD progression, but the mechanism is still unclear. This research aims to investigate the role of H19 in PD development and the detailed mechanisms. Our results showed that H19 was down-regulated in brain tissue of MPTP-induced PD mice (in vivo) and in MPP+ treated human neuroblastoma cells. miR-585-3p was verified to be a target of lncRNA H19 and was negatively regulated by H19. In addition, H19 could increase the expression of PIK3R3 through miR-585-3p. In vitro results indicated that H19 inhibited the apoptosis of MPP+ treated neuroblastoma cells by regulating of miR-585-3p. Moreover, in PD model mice, overexpression of H19 attenuated MPTP-induced neuronal apoptosis. In summary, our present research demonstrated that LncRNA H19 could attenuate neurons apoptosis in MPTP-induced PD mice as well as MPP+ treated neuroblastoma cells through regulating miR-585-3p/PIK3R3. The results may provide a potential theoretical experimental data for the clinical treatment of PD through targeting lncRNAs or miRNAs.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
References
Chunlei Liu JF, Wenke L (2019) Superoxide dismutase coding of gene polymorphisms associated with susceptibility to Parkinson’s disease. J Integr Neurosci 18(3):299–303. https://doi.org/10.31083/j.jin.2019.03.127
de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. https://doi.org/10.1016/S1474-4422(06)70471-9
Majidinia M, Mihanfar A, Rahbarghazi R, Nourazarian A, Bagca B, Avci ÇB (2016) The roles of non-coding RNAs in Parkinson’s disease. Mol Biol Rep 43(11):1193–1204. https://doi.org/10.1007/s11033-016-4054-3
Mathieu E-L, Belhocine M, Dao LTM, Puthier D, Spicuglia S (2014) Functions of lncRNA in development and diseases. Med Sci 30(8–9):790–796. https://doi.org/10.1051/medsci/20143008018
Yang G, Lu X, Yuan L (2014) LncRNA: a link between RNA and cancer. Biochim Biophys Acta (BBA)-Gene Regul Mech. 1839(11):1097–1109. https://doi.org/10.1016/j.bbagrm.2014.08.012
Zhou X, Xu J (2015) Identification of Alzheimer’s disease–associated long noncoding RNAs. Neurobiol Aging 36(11):2925–2931. https://doi.org/10.1016/j.neurobiolaging.2015.07.015
Liu S, Cui B, Dai Z-X, Shi P-K, Wang Z-H, Long Guo Y-Y. (2016) Non-coding RNA HOTAIR promotes Parkinson’s disease induced by MPTP through up-regulating the expression of LRRK2. Curr Neurovasc Res 13(2):115–120
Liu W, Zhang Q, Zhang J, Pan W, Zhao J, Xu Y (2017) Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell Biosci 7(1):19. https://doi.org/10.1186/s13578-017-0147-5
Yan W, Chen Z-Y, Chen J-Q, Chen H-M (2018) LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson’s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun 496(4):1019–1024. https://doi.org/10.1016/j.bbrc.2017.12.149
Kraus TFJ, Haider M, Spanner J, Steinmaurer M, Dietinger V, Kretzschmar HA (2017) Altered long noncoding RNA expression precedes the course of Parkinson’s disease—a preliminary report. Mol Neurobiol 54(4):2869–2877. https://doi.org/10.1007/s12035-016-9854-x
Su L, Wang C, Zheng C, Wei H, Song X (2018) A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson’s disease. BMC Med Genom 11(1):40. https://doi.org/10.1186/s12920-018-0357-7
Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14:S112–S115. https://doi.org/10.1016/j.parkreldis.2008.04.012
Sato HTH, Uchida T, Dote K, Ishihara M (1990) Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. In: Kodama K, Haze K, Hori M (eds) Clinical aspects of myocardial injury: from ischemia to heart failure. Kagakuhyoronsha Publishing Co., Tokyo, pp 56–64 (in Japanese)
Pham NV, Nguyen MT, Hu J-F, Vu TH, Hoffman AR (1998) Dissociation of IGF2 and H19 imprinting in human brain. Brain Res 810(1):1–8. https://doi.org/10.1016/S0006-8993(98)00783-5
Ding X, Yang Y, Sun Y, Xu W, Su B, Zhou X (2017) MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1. Clin Trans Oncol 19(5):546–552. https://doi.org/10.1007/s12094-016-1562-5
Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T et al (1998) The ubiquitin pathway in Parkinson’s disease. Nature 395(6701):451–452. https://doi.org/10.1038/26652.P
Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464–474. https://doi.org/10.1016/S1474-4422(09)70068-7
Cai X, Cullen BR (2007) The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 13(3):313–316. https://doi.org/10.1261/rna.351707
Liang W-C, Fu W-M, Wong C-W, Wang Y, Wang W-M, Hu G-X, Zhang L, Xiao L-J, Wan DC, Zhang JF (2015) The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6(26):22513
Frahm C, Srivastava A, Schmidt S, Mueller J, Groth M, Guenther M, Ji Y, Priebe S, Platzer M, Witte OWJNoa, (2017) Transcriptional profiling reveals protective mechanisms in brains of long-lived mice. Neurobiol Aging 52:23–31
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JL conceived and designed the experiments,YZ analyzed and interpreted the results of the experiments, QM performed the experiments.
Corresponding author
Ethics declarations
Conflict of interest
The authors state that there are no conflicts of interest to disclose.
Ethical Approval
All the procedure was in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Animal Ethics Committee of Guizhou People’s Hospital(Approval No. 2019-009).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, Y., Xia, Q. & Lin, J. LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson’s Disease Through Regulating miR-585-3p/PIK3R3. Neurochem Res 45, 1700–1710 (2020). https://doi.org/10.1007/s11064-020-03035-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-020-03035-w